InvestSMART

Percheron Therapeutics Limited (ASX: PER) - Announcements

- Current share price for PER : $0.003

ASX company news and announcements for Percheron Therapeutics Limited (PER) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Percheron Therapeutics Limited (PER) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Percheron Therapeutics Limited (PER), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Percheron Therapeutics Limited (PER)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$5 Appendix 4E and Annual Report 28 Aug 2025 1:33PM $0.011 $0.003 fallen by 72.73%
$5 New Preclinical Data Reported for HMBD-002 in Breast Cancer 6 Aug 2025 8:17AM $0.008 $0.003 fallen by 62.50%
$5 Quarterly Activities Report and Appendix 4C 31 Jul 2025 8:20AM $0.009 $0.003 fallen by 66.67%
$5 New Preclinical Data Reported for HMBD-002 23 Jul 2025 8:46AM $0.008 $0.003 fallen by 62.50%
$5 Change of Director's Interest Notice - Dr James Garner 1 Jul 2025 8:39AM $0.010 $0.003 fallen by 70%
$5 Ceasing to be a substantial holder from PVL 30 Jun 2025 11:05AM $0.010 $0.003 fallen by 68.42%
$5 Percheron Therapeutics Limited Corporate Presentation 27 Jun 2025 8:25AM $0.010 $0.003 fallen by 70%
$5 Percheron licenses HMBD-002 from Hummingbird Bioscience 26 Jun 2025 10:18AM $0.010 $0.003 fallen by 70%
$5 Trading Halt 25 Jun 2025 9:35AM $0.010 $0.003 fallen by 70%
$5 Change of Director's Interest Notice - Dr James Garner 20 May 2025 10:33AM $0.010 $0.003 fallen by 70%
$5 Change of Directors Interest Notice - Dr Charmaine Gittleson 20 May 2025 10:31AM $0.010 $0.003 fallen by 70%
$5 Notification regarding unquoted securities - PER 20 May 2025 10:29AM $0.010 $0.003 fallen by 70%
$5 Letter to ineligible shareholders 14 May 2025 8:19AM $0.010 $0.003 fallen by 70%
$5 Letter to eligible shareholders 14 May 2025 8:19AM $0.010 $0.003 fallen by 70%
$5 Proposed issue of securities - PER 7 May 2025 8:32AM $0.009 $0.003 fallen by 66.67%
$5 Bonus Loyalty Option Offer 7 May 2025 8:23AM $0.009 $0.003 fallen by 66.67%
$5 Quarterly Activities Report and Appendix 4C 30 Apr 2025 9:04AM $0.010 $0.003 fallen by 70%
$5 Results of General Meeting 24 Apr 2025 4:56PM $0.010 $0.003 fallen by 70%
$5 Change of Interest of Substantial Holder from PVL 22 Apr 2025 4:52PM $0.011 $0.003 fallen by 72.73%
$5 Percheron Therapeutics General Meeting 22 Apr 2025 12:34PM $0.011 $0.003 fallen by 72.73%
$5 Change of Director's Interest Notice - Dr Ben Gil Price 3 Apr 2025 8:41AM $0.010 $0.003 fallen by 70%
$5 Letter to Shareholders from the Board of Directors 2 Apr 2025 8:26AM $0.011 $0.003 fallen by 72.73%
$5 Change of Director's Interest Notice - Dr James Garner 31 Mar 2025 8:25AM $0.011 $0.003 fallen by 72.73%
$5 Notification of cessation of securities - PER 18 Mar 2025 4:34PM $0.010 $0.003 fallen by 70%
$5 Notice of General Meeting 14 Mar 2025 1:16PM $0.010 $0.003 fallen by 70%

51 - 75 of 178 results

Page 3 of 8

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.